COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 19 and 75 years old at the time of signing the consent form
- You are already scheduled by your doctor to take Fexuclu tablets (fexuprazan) for an approved medical reason
- You have at least one symptom that your doctor has decided needs medical treatment
- You are able to understand the study information, have chosen to take part freely, and are willing to sign a consent form allowing use of your personal data
Who may not be able to join:
- You have any medical reason that means you should not take Fexuclu tablets (fexuprazan), as listed in the official medication guidelines
- Your doctor decides, for any other reason, that it would not be appropriate for you to take part in this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jingun Kim, Dr., Masong Kim Internal Medicine Clinic
Phone: 82-10-2994-5887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The proportion of subjects with improvement in subjective symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.